PMC:7247521 / 29019-31631
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
418 | 1071-1075 | Gene | denotes | RdRp | Gene:43740578 |
419 | 1140-1144 | Gene | denotes | RdRp | Gene:43740578 |
420 | 1212-1220 | Gene | denotes | Helicase | Gene:164045 |
421 | 1281-1289 | Gene | denotes | Helicase | Gene:164045 |
423 | 867-876 | Species | denotes | 2019-nCov | Tax:2697049 |
425 | 1809-1812 | Disease | denotes | XCH | |
429 | 2141-2147 | Gene | denotes | ClC −6 | Gene:1185 |
430 | 1931-1943 | Disease | denotes | SGMH XCH WLS | |
431 | 2052-2055 | Disease | denotes | APL | MESH:D015473 |
433 | 1899-1907 | Disease | denotes | COVID-19 | MESH:C000657245 |
436 | 2575-2579 | Chemical | denotes | BXTM | |
437 | 2437-2440 | Disease | denotes | APL | MESH:D015473 |
446 | 208-223 | Gene | denotes | SX1, O1, X2, X1 | |
447 | 286-290 | Gene | denotes | Mpro | Gene:8673700 |
448 | 306-310 | Gene | denotes | RdRp | Gene:43740578 |
449 | 329-333 | Gene | denotes | RdRp | Gene:43740578 |
450 | 355-363 | Gene | denotes | Helicase | Gene:164045 |
451 | 382-390 | Gene | denotes | Helicase | Gene:164045 |
452 | 292-297 | Gene | denotes | PLpro | Gene:43740578 |
453 | 19-27 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T373 | 19-27 | SP_7 | denotes | COVID-19 |
T374 | 130-139 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T375 | 299-304 | PR:000000125 | denotes | nsp12 |
T376 | 322-327 | PR:000000125 | denotes | nsp12 |
T377 | 348-353 | PR:000000125 | denotes | nsp13 |
T378 | 364-372 | SO:0000346 | denotes | ADP site |
T379 | 375-380 | PR:000000125 | denotes | nsp13 |
T380 | 402-407 | PR:000000125 | denotes | nsp14 |
T381 | 416-421 | PR:000000125 | denotes | nsp14 |
T382 | 434-439 | PR:000000125 | denotes | nsp15 |
T383 | 460-465 | PR:000000125 | denotes | nsp16 |
T384 | 480-489 | PG_4 | denotes | N protein |
T385 | 500-509 | PG_2 | denotes | E protein |
T386 | 511-514 | CHEBI:24870;CHEBI:24870 | denotes | ion |
T387 | 686-695 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T388 | 738-747 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T389 | 793-802 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T397 | 867-876 | SP_7 | denotes | 2019-nCov |
T398 | 1899-1907 | SP_7 | denotes | COVID-19 |
T399 | 2367-2371 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T400 | 2543-2547 | CHEBI:23888;CHEBI:23888 | denotes | drug |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T95 | 276-284 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T96 | 316-319 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T97 | 342-345 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T98 | 409-413 | Body_part | denotes | ExoN | http://purl.org/sig/ont/fma/fma84120 |
T99 | 482-489 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T100 | 502-509 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T101 | 877-885 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T102 | 1081-1084 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T103 | 1153-1156 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T104 | 1360-1364 | Body_part | denotes | ExoN | http://purl.org/sig/ont/fma/fma84120 |
T105 | 1644-1651 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T106 | 1714-1721 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T60 | 19-27 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T61 | 1899-1907 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T247 | 141-143 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T248 | 204-206 | http://purl.obolibrary.org/obo/CLO_0008933 | denotes | S5 |
T249 | 229-232 | http://purl.obolibrary.org/obo/CLO_0007875 | denotes | MS1 |
T250 | 229-232 | http://purl.obolibrary.org/obo/CLO_0052410 | denotes | MS1 |
T251 | 902-904 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T252 | 905-907 | http://purl.obolibrary.org/obo/CLO_0008933 | denotes | S5 |
T253 | 2141-2144 | http://purl.obolibrary.org/obo/CLO_0002494 | denotes | ClC |
T254 | 2265-2268 | http://purl.obolibrary.org/obo/CLO_0002494 | denotes | ClC |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T192 | 4-15 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
T193 | 200-202 | Chemical | denotes | M3 | http://purl.obolibrary.org/obo/CHEBI_51083|http://purl.obolibrary.org/obo/CHEBI_53453 |
T195 | 204-206 | Chemical | denotes | S5 | http://purl.obolibrary.org/obo/CHEBI_29386 |
T196 | 225-227 | Chemical | denotes | O2 | http://purl.obolibrary.org/obo/CHEBI_15379 |
T197 | 276-284 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T198 | 364-367 | Chemical | denotes | ADP | http://purl.obolibrary.org/obo/CHEBI_16761|http://purl.obolibrary.org/obo/CHEBI_456216|http://purl.obolibrary.org/obo/CHEBI_73342 |
T201 | 482-489 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T202 | 502-509 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T203 | 511-514 | Chemical | denotes | ion | http://purl.obolibrary.org/obo/CHEBI_24870 |
T204 | 877-885 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T205 | 896-898 | Chemical | denotes | M3 | http://purl.obolibrary.org/obo/CHEBI_51083|http://purl.obolibrary.org/obo/CHEBI_53453 |
T207 | 905-907 | Chemical | denotes | S5 | http://purl.obolibrary.org/obo/CHEBI_29386 |
T208 | 927-929 | Chemical | denotes | O2 | http://purl.obolibrary.org/obo/CHEBI_15379 |
T209 | 1221-1224 | Chemical | denotes | ADP | http://purl.obolibrary.org/obo/CHEBI_16761|http://purl.obolibrary.org/obo/CHEBI_456216|http://purl.obolibrary.org/obo/CHEBI_73342 |
T212 | 1644-1651 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T213 | 1714-1721 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T214 | 1722-1725 | Chemical | denotes | ion | http://purl.obolibrary.org/obo/CHEBI_24870 |
T215 | 2367-2371 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T216 | 2543-2547 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T100 | 511-522 | http://purl.obolibrary.org/obo/GO_0022831 | denotes | ion channel |
T101 | 1722-1733 | http://purl.obolibrary.org/obo/GO_0022831 | denotes | ion channel |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T216 | 0-525 | Sentence | denotes | The application of COVID-19 docking server and Discovery Studio software elucidated the interactions between the 20 lead-likeness compounds (S1, W5, MX17, MX16, W11, M5, XO1, MXO1, SO1, WO1, X4, MX8, M3, S5, SX1, O1, X2, X1, O2, MS1) and the 10 nonstructural and 2 structural proteins (Mpro, PLpro, nsp12 [RdRp with RNA], nsp12 [RdRp without RNA], nsp13 [Helicase ADP site], nsp13 [Helicase NCB site], nsp14 [ExoN], nsp14 [N7-MTase], nsp15 [endoribonuclease], nsp16 [2′-O-MTase], N protein NCB site, E protein [ion channel]). |
T217 | 526-580 | Sentence | denotes | The docking scores were depicted in Table 3, Table 4 . |
T218 | 581-725 | Sentence | denotes | The smaller of docking score, the lower of energy would be required, which means the binding between the compounds and the targets are stronger. |
T219 | 726-803 | Sentence | denotes | There are 9 compounds presenting better bonding ability than other compounds. |
T220 | 804-886 | Sentence | denotes | Table 3 Docking score between specific ingredients of QFPD and 2019-nCov proteins. |
T221 | 887-929 | Sentence | denotes | Molecule M3 M5 S1 S5 W11 W5 X1 X2 X4 O1 O2 |
T222 | 930-998 | Sentence | denotes | Main Protease −7.7 −7.3 −6.8 −6.9 −7.2 −7.5 −7.1 −7.9 −7.3 −7.1 −7.4 |
T223 | 999-1070 | Sentence | denotes | Papain-like protease −8.7 −8.5 −9.9 −7.7 −8 −8 −8.4 −8.7 −8.2 −8.6 −8.2 |
T224 | 1071-1139 | Sentence | denotes | RdRp with RNA −8.4 −8.5 −8.5 −8.3 −9.1 −9.1 −8.4 −8.2 −8.2 −8.3 −8.6 |
T225 | 1140-1211 | Sentence | denotes | RdRp without RNA −6.8 −6.8 −6.9 −6.8 −6.7 −6.9 −7.1 −7.2 −6.5 −7.3 −7.1 |
T226 | 1212-1280 | Sentence | denotes | Helicase ADP site −6.3 −6.3 −7.3 −6.5 −6 −6 −6.3 −6.5 −6.2 −6.1 −6.5 |
T227 | 1281-1353 | Sentence | denotes | Helicase NCB site −7.9 −6.9 −7.2 −7.1 −7.2 −7.2 −7.4 −7.5 −7.3 −7.4 −7.4 |
T228 | 1354-1420 | Sentence | denotes | Nsp14(ExoN) −6.8 −6.6 −6.3 −6.4 −6.9 −6.8 −6.7 −6.9 −6.4 −6.6 −6.9 |
T229 | 1421-1489 | Sentence | denotes | Nsp14(N7-MTase) −8.8 −8.1 −8.5 −7.5 −8.4 −8.4 −8.3 −8.5 −8 −8.3 −8.5 |
T230 | 1490-1568 | Sentence | denotes | Nsp15(endoribonuclease) −6.6 −6.3 −6.3 −5.9 −6.2 −6.2 −6.2 −6.3 −6.2 −6.4 −6.4 |
T231 | 1569-1641 | Sentence | denotes | Nsp16(2′-O-MTase) −7.5 −7.4 −7.5 −7.2 −8.2 −8.2 −7.7 −7.9 −7.7 −7.9 −8.4 |
T232 | 1642-1711 | Sentence | denotes | N protein NCB site −7.6 −7.5 −7.8 −7.6 −7.6 −7.6 −8 −8 −7.5 −7.6 −7.6 |
T233 | 1712-1787 | Sentence | denotes | E protein(ion channel) −8.1 −7 −7.8 −6.7 −6.4 −6.4 −7.2 −7.3 −7.2 −7.1 −6.8 |
T234 | 1788-1816 | Sentence | denotes | M: MXSG, S: SGMH, X: XCH, O: |
T235 | 1817-1824 | Sentence | denotes | Others. |
T236 | 1825-1916 | Sentence | denotes | Table 4 Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. |
T237 | 1917-1960 | Sentence | denotes | Topology MXSG SGMH XCH WLS Others BXTM YDBF |
T238 | 1961-2006 | Sentence | denotes | DTS 25.66 26.71 21.02 17.64 23.16 14.52 22.71 |
T239 | 2007-2051 | Sentence | denotes | AC −4.63 −5.21 −3.02 −3.49 −5.38 −2.32 −3.78 |
T240 | 2052-2094 | Sentence | denotes | APL 13.35 13.40 9.96 6.49 10.66 4.59 11.17 |
T241 | 2095-2140 | Sentence | denotes | CoC −1.44 −1.64 −1.59 −1.30 −1.23 −1.15 −1.25 |
T242 | 2141-2186 | Sentence | denotes | ClC −6.24 −6.46 −6.45 −6.36 −5.88 −6.46 −6.52 |
T243 | 2187-2372 | Sentence | denotes | Average connectivity (AC), Connection centrality (CoC), Closeness centrality (ClC): the larger the quotient is, the more stable the network and, the less the influence made by the drug. |
T244 | 2373-2548 | Sentence | denotes | Disturbance total score (DTS), Average length of shortest path (APL), : the larger the quotient is, the less stable the network and, the larger the influence made by the drug. |
T245 | 2549-2580 | Sentence | denotes | Negative control formula: BXTM. |
T246 | 2581-2612 | Sentence | denotes | Positive control formula: YDBF. |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T3 | 186-189 | GlycoEpitope | denotes | WO1 | http://www.glycoepitope.jp/epitopes/AN0690 |